• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT LABORATORIES (IRVING IA/CC) TOTAL BILIRUBIN; TOTAL BILIRUBIN REAGENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT LABORATORIES (IRVING IA/CC) TOTAL BILIRUBIN; TOTAL BILIRUBIN REAGENT Back to Search Results
Model Number 6L45-41
Medical Device Problem Code High Test Results (2457)
Health Effect - Clinical Code No Known Impact Or Consequence To Patient (2692)
Date of Event 03/19/2020
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
A review of tickets determined normal complaint activity for lot 55406uq07 and no trends for the issue for the product.Return testing was not completed as returns were not available.A review of the manufacturing documentation did not identify any issues associated with the customer's observation.A review of the total bilirubin reagent and architect system operations manual product labeling concluded that the issue is sufficiently addressed.Based on the investigation no product deficiency was identified for the architect total bilirubin reagent, lot 55406uq07.This issue was previously reported under mdr number 1415939-2020-00031.The suspect medical device architect total bilirubin reagent, list number 06l45-41, lot 55406uq07, was filed on the incorrect manufacturing site abbott laboratories, (b)(4).The correct manufacturing site is abbott laboratories (b)(4).
 
Event or Problem Description
The customer observed erratic total bilirubin results on one patient on the architect c8000 analyzer, serial number (b)(4).The following data was provided: total bilirubin = 5.4mmol/l, direct bilirubin = 6.6.The sample was tested on another architect c8000, serial number (b)(4) - total bilirubin = 6.5mmol/l, direct bilirubin = 7.0.The sample was then retested on sn (b)(4) - total bilirubin = 1.9mmol/l, direct bilirubin = 5.9.There was no impact to patient management reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TOTAL BILIRUBIN
Common Device Name
TOTAL BILIRUBIN REAGENT
Manufacturer (Section D)
ABBOTT LABORATORIES (IRVING IA/CC)
1915 hurd drive
irving TX 75038
MDR Report Key10028824
Report Number3016438761-2020-00062
Device Sequence Number766021
Product Code CIG
UDI-Device Identifier00380740011383
UDI-Public00380740011383
Combination Product (Y/N)N
Initial Reporter CountryKZ
PMA/510(K) Number
K060574
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source foreign,health professional
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date (Section B) 05/06/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date12/31/2020
Device Model Number6L45-41
Device Catalogue Number06L45-41
Device Lot Number55406UQ07
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 05/05/2020
Initial Report FDA Received Date05/06/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
-
-